| # | Drug | Count |
|---|---|---|
| 0 | PEGFILGRASTIM | 137 |
| 1 | DOCETAXEL | 92 |
| 2 | DOCETAXEL ANHYDROUS | 92 |
| 3 | CARBOPLATIN | 77 |
| 4 | CYCLOPHOSPHAMIDE | 73 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 73 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 73 |
| 7 | FILGRASTIM | 64 |
| 8 | PACLITAXEL | 46 |
| 9 | PACLITAXEL (AIBUMIN-BOUND) | 46 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADENINE | 1 | 0.0204 |
| 1 | PEGFILGRASTIM | 137 | 0.0114 |
| 2 | ADAGRASIB | 5 | 0.0044 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 16 | 0.0035 |
| 4 | CARTEOLOL HYDROCHLORIDE | 1 | 0.0030 |
| 5 | EPIRUBICIN HYDROCHLORIDE | 16 | 0.0025 |
| 6 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 7 | ALLOPURINOL SODIUM | 1 | 0.0018 |
| 8 | APREPITANT | 13 | 0.0017 |
| 9 | FILGRASTIM | 64 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Leukocyte Growth Factor [EPC] | 189 |
| 1 | Platinum-based Drug [EPC] | 140 |
| 2 | Microtubule Inhibitor [EPC] | 138 |
| 3 | Corticosteroid [EPC] | 123 |
| 4 | Alkylating Drug [EPC] | 73 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 64 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 58 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 53 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 51 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 46 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 3 | 0.0017 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 13 | 0.0015 |
| 3 | Leukocyte Growth Factor [EPC] | 189 | 0.0013 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |
| 5 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 6 | Microtubule Inhibitor [EPC] | 138 | 0.0008 |
| 7 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 3 | 0.0007 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 64 | 0.0006 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 45 | 0.0006 |